Dasatinib 50 Mg · Strip

Dasatrue 50 Mg Tablet

Rx (Prescription Medicine)

USD $ 30.00

USD $ 0.50 per tablet

Upload prescription Ask about this medicine
  • Dispatched from licensed pharmacy partners
  • Tracked worldwide shipping
  • Secure payment

Dasatrue 50mg Tablet is used to treat specific types of leukemia by inhibiting cancer cell growth. It is taken orally as prescribed by your doctor.

Key facts

Active ingredient
Dasatinib
Strength
50 Mg
Form
Tablet
Drug class
Generic
Brand
Dasatrue
Manufacturer
Cipla Ltd.
Pack sizes
60 Tablets

Description

Dasatrue 50mg Tablet is a medication containing Dasatinib as its active ingredient. It is primarily used in the treatment of certain types of cancer, specifically chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Dasatinib works by inhibiting specific enzymes that promote cancer cell growth, thereby slowing down or stopping the progression of the disease. This medication is available in tablet form for oral administration. Patients should take Dasatrue 50mg Tablet exactly as prescribed by their healthcare provider. It is crucial to inform your doctor about any pre-existing medical conditions, especially heart problems, liver or kidney disease, and any other medications you are taking to avoid potential interactions. Common side effects may include diarrhea, nausea, rash, and fatigue. Store the tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

Additional information

Medicine Form

Tablet

Rx Status

Prescription Required

Medicine Type

Allopathy

Brand Name

Molecule

Strength

50 Mg

Medicine Form

Tablet

Pack Quantity

60 Tablets

Packaging Type

Strip

Medicine Type

Generic

Country Of Origin

India

Rx Status

Rx (Prescription Medicine)

Same molecule & strength

Other brands of Dasatinib 50 Mg — the same active ingredient at the same strength, from a different manufacturer.

On this page
  1. Key facts
  2. Description
  3. Additional information
  4. Same molecule

Content integrity

Medically reviewed by

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Last reviewed 11/08/2026

Shipping to your country

Options
Fast Delivery – Arrives in 7–12 Days, Express shipping (Arriving in 3-7 days )
Free over
USD $ 200.00